We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
(+18%)
Cap. Flow
+$2.97B
Cap. Flow
% of AUM
6.1%
Top 10 Holdings %
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$305M |
| 2 |
CVS Health
CVS
|
+$190M |
| 3 |
Novartis
NVS
|
+$175M |
| 4 |
Broadcom
AVGO
|
+$154M |
| 5 |
Western Digital
WDC
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$260M |
| 2 |
UnitedHealth
UNH
|
+$217M |
| 3 |
United Parcel Service
UPS
|
+$140M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$137M |
| 5 |
McKesson
MCK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.38% |
| 2 | Healthcare | 15.25% |
| 3 | Technology | 13.09% |
| 4 | Industrials | 10.62% |
| 5 | Energy | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGR
251
DELISTED
Hanger Inc.
HNGR
| $25.6M | 0.05% |
650,397
-10,357
| -2% | -$380K |
|
|
AREX
252
DELISTED
Approach Resources Inc.
AREX
| $25.5M | 0.05% |
1,320,065
+423,380
| +47% | +$10.4M |
|
|
HTS
253
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $25.3M | 0.05% |
1,547,363
+130,899
| +9% | +$2.29M |
|
254
Scorpio Tankers
STNG
$3.96B
| $25.1M | 0.05% |
212,864
-20,437
| -9% | -$2.29M |
|
|
SMA
255
DELISTED
SYMMETRY MEDICAL INC
SMA
| $24.3M | 0.05% |
2,410,709
-305,895
| -11% | -$2.66M |
|
256
Maximus
MMS
$3.14B
| $23.8M | 0.05% |
540,336
-180,564
| -25% | -$8.32M |
|
257
JetBlue
JBLU
$1.96B
| $23.7M | 0.05% |
2,773,755
-353,270
| -11% | -$2.81M |
|
|
ASNA
258
DELISTED
Ascena Retail Group, Inc.
ASNA
| $23.5M | 0.05% |
55,636
-14,897
| -21% | -$6.08M |
|
|
LBY
259
DELISTED
Libbey, Inc.
LBY
| $23.4M | 0.05% |
1,114,720
+177,202
| +19% | +$3.9M |
|
|
SGI
260
Somnigroup International
SGI
$15.1B
| $23.1M | 0.05% |
1,713,688
-38,708
| -2% | -$445K |
|
|
KW
261
DELISTED
Kennedy-Wilson Holdings
KW
| $23.1M | 0.05% |
1,037,805
+76,360
| +8% | +$1.53M |
|
|
KND
262
DELISTED
Kindred Healthcare
KND
| $23M | 0.05% |
1,166,846
+30,845
| +3% | +$497K |
|
|
SYKE
263
DELISTED
SYKES Enterprises Inc
SYKE
| $22.6M | 0.05% |
1,038,059
-22,843
| -2% | -$458K |
|
|
RPXC
264
DELISTED
RPX Corporation
RPXC
| $22.6M | 0.05% |
1,338,568
+557,791
| +71% | +$9.49M |
|
265
Enerpac Tool Group
EPAC
$1.77B
| $22.6M | 0.05% |
617,055
-1,337,404
| -68% | -$50.8M |
|
266
Titan Machinery
TITN
$466M
| $22.2M | 0.05% |
1,248,511
+311,527
| +33% | +$5.25M |
|
267
Textron
TXT
$16.6B
| $22.1M | 0.05% |
600,483
+38,641
| +7% | +$1.19M |
|
|
268
Halliburton
HAL
$27.9B
| $22M | 0.05% |
433,323
-5,030,014
| -92% | -$260M |
|
|
MIG
269
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $22M | 0.05% |
3,158,504
-595,711
| -16% | -$4.1M |
|
270
Hanover Insurance
THG
$7.63B
| $21.9M | 0.04% |
367,104
-2,280
| -0.6% | -$134K |
|
271
Ball Corp
BALL
$17B
| $21.8M | 0.04% |
843,630
+189,238
| +29% | +$4.62M |
|
|
TXNM
272
TXNM Energy Inc
TXNM
$6.47B
| $21.2M | 0.04% |
879,881
-15,344
| -2% | -$359K |
|
|
GLDD
273
DELISTED
Great Lakes Dredge & Dock
GLDD
| $21.1M | 0.04% |
2,297,480
-12,266
| -0.5% | -$103K |
|
274
Labcorp
LH
$24.3B
| $21.1M | 0.04% |
268,340
+164,290
| +158% | +$14M |
|
275
Huntsman Corp
HUN
$2.24B
| $21.1M | 0.04% |
855,942
+256,352
| +43% | +$5.84M |
|
Similar funds
Boston Partners's Q4 2013 Portfolio in Review
As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.
- Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
- Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
- Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
- Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
- Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
- Boston Partners opened 71 new positions and closed 53 in Q4 2013.
- Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.
Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.